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Foreword
As the European Commissioner for Research, Innovation and Science, a big part of my job 
is to help create the conditions for a more dynamic and innovative Europe. 
Realising the “Innovation Union’’ is one of the seven Flagship initiatives announced in the 
European Commission’s Europe 2020 Strategy. It is my contribution to getting Europe back 
on track to dynamic and sustainable growth. A Europe where we use excellent research and 
innovation to tackle head-on the problems – the Grand Challenges – facing our society now 
and in the future, such as an ageing population, the effects of climate change, and reduced 
availability of resources.
When I addressed the ﬁ  rst European Research Area Board (ERAB) conference in Seville 
in May this year, I challenged ERAB to draw up at least ten concrete proposals on how 
research, innovation and science can contribute to addressing these Grand Challenges and 
in doing so, contribute to building Europe’s post-crisis smart, green economy and society. 
This triggered lively discussions in Seville and I particularly appreciated the active and 
enthusiastic participation of young researchers and scientists in this debate. Their inter-
ventions inspired me to be even more action-oriented in my policies. We must move from 
listing problems to identifying concrete solutions.
I am therefore delighted to see that in this second annual report ERAB not only lists ten 
substantive actions, but also makes them more operational by adding detailed recom-
mendations for each one. The “Policy proposals for developing a world class research and 
innovation space in Europe 2030’’ are indeed concrete enough to be taken on board in my 
ongoing work. As I promised in Seville, I will pay close attention to them and explore how 5
they can be used to support the Innovation Union Flagship initiative which has recently 
been proposed by the European Commission. 
The Innovation Union Flagship makes clear that I would like ERAB to continue to provide 
the Commission with its invaluable insight, ideas and experience. This report shows that 
the ambition outlined by ERAB in its ﬁ  rst annual report – of realising a “New Renaissance” 
in Europe – can be translated into concrete actions.  
Máire Geoghegan-Quinn
European Commissioner 
for Research, Innovation and Science6
The European Research Area Board (ERAB) published its strategic vision for the next 20 
years in October 2009 entitled Preparing Europe for a New Renaissance. This strategic 
vision of a successful European Research Area (ERA) is still valid. During the last year this 
document has been widely disseminated and commented upon by many bodies, culmi-
nating with a major conference held in May 2010 under the Spanish Presidency where all 
aspects of ERAB’s recommendations were subject to scrutiny by many stakeholders (see 
Annex 3).
These discussions, in addition to the current economic climate, have underlined the need 
for cohesive, fast and ﬂ  exible action. If we don’t act immediately, we face the prospect of 
economic and social decline in Europe and further environmental degradation.
At the Spanish conference, ERAB received the view from all stakeholders that the stra-
tegic vision was close to ‘mission impossible’ but that, nevertheless, urgent action was 
needed and that Europe is well placed to take a global lead with other partners to address 
and agree solutions to the grand challenges in a coherent way. Other regions of the world 
are looking at the development of ERA and are seeking to create similar approaches. We 
need to work with them. In addition there was a plea to explain more explicitly the role that 
humanities and social sciences can play in helping ﬁ  nd solutions to the challenges before 
us. 
Subsequently, the new Commissioner for Research, Innovation and Science, Máire 
Geoghegan-Quinn, challenged ERAB to provide 10 key recommendations for her to take 
forward into the new Research and Innovation Policy. ERAB took up this challenge with 
enthusiasm and responded immediately.
1.   Time to act in a changing 
environment 7
2.   Ten key recommendations 
for action
In its ﬁ  rst annual report ERAB argued that the challenges before us are of such an order of 
magnitude that Europe needs to mobilise all its talent in science, research and innovation 
to address them in such a way that it leads to a new Renaissance. In that same report ERAB 
stated that, in doing so, Europe would also lay the foundations for the growth sectors of the 
future. In the report ERAB presented 30 milestones for ERA by 2030 to measure progress 
in the years ahead. Building the European Research Area is indeed a long and difﬁ  cult task 
and for that a clear plan is needed. 
Outlining that plan was at the core of ERAB’s second full year of work and led ERAB to come 
up with 76 detailed recommendations and their expected impact (see Annex 2). These rec-
ommended actions, organised around the milestones of the ﬁ  rst report, were developed 
and divided into four broad themes: 
  ■ united ERA in a global world
  ■ science, society and policy
  ■ open innovation
  ■ an ERA to deliver excellence and cohesion
The Commissioner asked ERAB to condense the 76 recommendations to 10 key messages 
summarised below.8
Recommendations for immediate action
1.  Create a single EU-wide patent and an Open Innovation Charter
The need for a Community Patent has been widely recognised yet has reached an impasse 
as a result of vested interests and language and legal barriers. The present deadlock is a 
signiﬁ  cant barrier to rapid exploitation of inventions compared with similar global econo-
mies. Early publication and easy access to electronic patent databases aids the innovation 
process. For the time being, the exclusive route for protection in Europe is the European 
patent published, then granted, by the European Patent Ofﬁ  ce. Discussions on the Com-
munity Patent have been ongoing for more than 30 years. The issue is to succeed in ﬁ  nding 
a uniﬁ  ed procedure which will bring protection in all the 27 Member States with only one 
entry point. The complexity of the current situation is a disincentive to rapid exploitation 
of ideas. 
❫❫❫  ERAB recommends the Belgium Presidency make the Community Patent a reality as 
soon as possible.
The complex mechanisms involved in patenting are a challenge for academic researchers. 
They should keep in mind the potential use of their results in order to protect, in advance, 
incoming commercial values. Academic researchers are more knowledge-focused than 
market-oriented, since citations of publications are a major measure of academic perform-
ance. This needs to be addressed within universities in considering individual promotion. 
❫❫❫  ERAB recommends that awareness among EU researchers on intellectual property 
rights (including trade marks) should be raised, especially among researchers dur-
ing their training, and that academic credibility and ratings place more importance on 
these marks of esteem.
Although some companies have implemented explicit open innovation practices, an open 
innovation mindset is not yet in the genes of Europe’s RDI actors, nor of its policymakers. 
In practice, many public and private actors still ﬁ  nd it difﬁ  cult to establish fruitful, sustain-
able collaborations and would beneﬁ  t from practical guidelines for engaging in win-win 
collaborations and fruitful knowledge exchanges. 
❫❫❫  ERAB recommends developing an Open Innovation Charter, to be ready for endorse-
ment by key stakeholders in 2012. 
This Open Innovation Charter should build on the 2008 EC Recommendation on the man-
agement of intellectual property in knowledge-transfer activities and Code of Practice 
for universities and other public research organisations. Likewise, the guidelines of the 
Responsible Partnering Handbook should be followed. Completing the Open Innovation 
Charter by 2012 would be well in time for having it included as a reference (not as an eligi-
bility requirement) in the selection criteria and Guides for Applicants in future frameworks 
for funding. With the eighth framework programme (FP8) acting as a standard, the char-
ter’s wider use in relevant national programmes should be promoted.9
❫❫❫  ERAB recommends against imposing mandatory adherence to the Open Innovation 
Charter by all beneﬁ  ciaries of such programmes or even by all RDI actors, to prevent 
a regulatory straightjacket stiﬂ  ing innovation and in line with the Union’s efforts 
towards ‘Better Regulation and Simpliﬁ  cation’. 
When ﬁ  rms engage with publicly funded research organisations for contract research or 
collaborative research, certain restrictions from the EU state aid framework apply in order 
to limit indirect state aid to ﬁ  rms and avoid undue distortion of competition. 
❫❫❫  ERAB recommends that these restrictions need to be clariﬁ  ed (as elaborated in the 
Responsible Partnering Handbook) in the forthcoming revision of the state aid frame-
work and have to be complemented by operational guidance in the Open Innovation 
Charter.
2.  Agree on a fast-track timeline for a full and widespread implementation 
of pre-commercial procurement of research and development (R & D)
The challenge is to exploit the huge, largely untapped potential of the public sector pur-
chasing power (some 17 % of GDP (1)) to drive innovation and stimulate private R & D, while 
at the same time enabling governments to perform their public tasks and address societal 
challenges more efﬁ  ciently and effectively. The US public sector is spending USD 50 billion 
per year in procurement of R & D, an amount which is 20 times higher than in Europe and 
represents approximately half of the overall R & D investment gap between the US and 
Europe (2). Earmarking at least 2 % of public procurement expenditure in the EU for procur-
ing R & D services and innovative technologies from the private sector would amount to 
some EUR 40 billion, equivalent to almost ﬁ  ve times total state aid for R & D and innovation 
in the EU (EUR 8.6 billion in 2008 or 0.07 % of GDP (3)). A speciﬁ  c new instrument for the 
public sector to stimulate demand for innovation is the Pre-Commercial Procurement (PCP) 
of R & D services from the private sector. Modelled upon successful US examples (Depart-
ment of Defense (DoD), NASA, National Institutes of Health (NIH)) it was put forward by the 
Commission at the end of 2007. While exempted from the EU Public Procurement Direc-
tives, the PCP scheme entails risk-beneﬁ  t sharing between public procurers and private 
suppliers in the R & D phase preceding commercial procurement tenders. However, the 
potential of this novel scheme still remains largely untapped.
❫❫❫  ERAB recommends agreeing on a fast-track timeline for a full and widespread imple-
mentation of pre-commercial procurement of R & D. 
For this purpose, the forthcoming meeting of the European Council dedicated to research 
and innovation is a unique opportunity, building on the earlier endorsement of PCP by the 
European Council in 2008 and a strongly supportive resolution from the European Parlia-
ment in 2009. 
(1)  In 2007, total public procurement of goods and services in the EU amounted to EUR 2.1 trillion or 16.9 % 
of GDP. Public procurement predominantly takes place at local and regional levels. At national level, most 
public procurement stems from ministries other than those responsible for research and innovation. 
(2)  Pre-commercial Procurement: Driving innovation to ensure sustainable high-quality public services 
in Europe, European Commission, COM(2007) 799, see http://ec.europa.eu/information_society/tl/
research/priv_invest/pcp/documents/commpcp_en.pdf
(3)  Commission staff working document accompanying the state aid scoreboard — Autumn 2009 Update, 
see http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SEC:2009:1638:FIN:EN:PDF10
❫❫❫  ERAB recommends the following immediate actions: 
  ■ recognise that public procurement of innovative solutions and technologies entails 
risks and promote the acceptance of a certain degree of risk among governments, 
politicians and the general public at large;
  ■ provide public procurers with tools for managing rather than avoiding risks;
  ■ develop smart incentives from the EU budget for public procurers to use PCP, to 
share risks and bundle procurement among Member States to create more interest-
ing markets;
  ■ make (part of) EU co-funding in the context of the Structural Funds conditional on 
procurement of innovative technologies and R & D, also as a means of gearing cohe-
sion policy more towards stimulating R & D and innovation;
  ■ clarify that PCP will be assumed to take place at competitive conditions and without 
State aid, provided that the tendering process ensures transparency, openness, fair-
ness and pricing conditions.
3.  Concentrate research, development & innovation funding around a 
selection of themes relevant for ‘Europe 2020: A strategy for smart, 
sustainable and inclusive growth’
To have real impact in a world which is becoming more competitive every day, the research, 
development & innovation funding has to be more focused. In many regions of the world 
we observe a stronger focus of research on high-impact research topics, yet Europe contin-
ues to split up research funding between quite a number of directorates and research pro-
grammes. Funding schemes need to be sufﬁ  ciently ﬂ  exible to adapt and respond to chang-
ing market conditions and requirements. Locking instruments in place for seven years 
and expecting them to be ﬁ  t for purpose over the whole framework programme period 
is nonsense. The Member and Associate States, with the Commission and the European 
Parliament, should identify those key areas where a common approach is appropriate and 
agree on the support mechanisms necessary to take these forward. Coordination rather 
than duplication of support is essential.
❫❫❫  ERAB recommends that a focused, fast and efﬁ  cient implementation of a limited 
number of high-impact research programmes is pursued. 
While we plead for this attention to the grand challenges, ERAB is ﬁ  rm in its commitment 
to further support for the European Research Council which allows the bottom-up encour-
agement of new and high-risk projects. The hallmark of EC funding should be that it is 
speedy and ﬂ  exible with credit being given to quality outputs rather than slavish attention 
to processes that stiﬂ  e innovation. Above all there needs to be political acceptance of a 
much higher tolerance of risk than at present and ﬂ  exibility in working conditions if real 
breakthroughs are to be achieved. The current situation is a major dis-incentive for all par-
ties and especially SMEs. 11
4.  Create an annual ‘City/Region of Innovation in Europe’
To achieve a ‘New Renaissance’ in Europe, we must foster the visibility of science and inno-
vation, gain trust and strengthen the cooperation between researchers, innovators and 
society. Research development and innovation should be shown to be valuable and attrac-
tive. Scientiﬁ  c institutions as well as companies should be able to present solutions for 
pressing problems. Currently the gap between the researchers and innovators on the one 
side and the public as well as politicians on the other side is too wide. If we call for a better 
understanding and a shared responsibility between science, policy and society we need an 
open and in-depth dialogue about chances and risks involved in innovation and examples 
of successful inventions. A European Capital of Research and Innovation would highlight 
the quality and the European and international dimension of research and innovation and 
gain the attention of the public.
❫❫❫  ERAB recommends that, analogous to the European Capital of Culture, the European 
Union should award the title of the European Capital/Region of Research, Develop-
ment and Innovation in open competition. 
While ideas should come from the proposers, a key criterion should be whether the inno-
vations developed can be generally applied in all Member States and are not just locally 
speciﬁ  c.
5.  Issue an EU framework directive on research & innovation 
focusing particularly on creating a single market for research, 
development and innovation
EU research & innovation policy is becoming a policy ﬁ  eld embedded in a clear legal frame-
work as a result of the reinforcement of research and innovation in the Treaty on the Func-
tioning of the European Union, the clariﬁ  cation of the legal force and enforceability of the 
Charter of Fundamental Rights of the European Union and the explicit desire of creating an 
internal market for knowledge (ﬁ  fth freedom, free circulation of knowledge and research-
ers). This needs a clear structure that outlines the hierarchy of ambitions. 
❫❫❫  ERAB recommends that the EC sets out its big ambitions in a framework directive. 
This directive should allow action to:
  ■ harmonise and strengthen pan-European public and pre-commercial procurement 
schemes;
  ■ create a European research certiﬁ  cate/passport to enhance mobility of researchers;
  ■ support pan-European graduate/research schools focused on grand challenges, 
including the possibility of developing a high-level European/international PhD;
  ■ foster ﬂ  exible cross-border research funding;
  ■ establish a European peer review college for research projects addressing grand 
challenges. 12
Recommendations for medium-term actions
6.  Fully implement pre-commercial procurement of research, development 
and innovation around a few commonly agreed big projects
Following on from the respective short-term recommendations outlined above, it is neces-
sary to decide on which services and technologies would be chosen for pre-commercial 
public procurement on a European-wide basis. While proposals might come from individ-
ual Member States and from the Commission, these will need to be integrated.
❫❫❫  ERAB recommends the creation of a body that would implement the process for this 
pre-commercial procurement of RDI. 
This could be a further development of the European Institute of Innovation and Tech-
nology or a similar body able to take high risks and to look for projects that genuinely 
tackle new technologies. Again, every effort should be used to present these procurement 
projects in a high-proﬁ  le way. It is essential that all citizens own the success or failure of 
such programmes. 
7.  Concentrate and streamline all R & D funding in the eighth framework 
programme (FP8) by minimising management obligations for all funding 
schemes and by earmarking 30 % of the Structural Funds and 10 % 
of the common agricultural policy (CAP) for RDI projects 
With each successive framework programme new instruments have been introduced giv-
ing rise to a complex range of funding opportunities. In addition to the potentially over-
lapping goals, the speciﬁ  c rules associated with each instrument vary. Today we need a 
comprehensive approach to research, development and innovation. However, at present 
initiatives are spread across almost every directorate in different formats. FP8 represents 
an opportunity to streamline these operations in such a way that there is greater simplicity 
for the applicants, clarity of the rationale for the different programmes and cohesion in the 
investment that the Commission makes in RDI. Furthermore this is an opportunity to look 
at the full range of RDI support across the Community and not just those supported under 
the framework programme.  
❫❫❫  ERAB recommends a more integrated approach to the total spend on RDI that ensures 
that all Commission-supported programmes are assessed to ensure optimisation of 
investment and to avoid duplication. This exercise should take account of Member 
State investments and build on them where appropriate. 
Under the seventh framework programme (FP7) a signiﬁ  cant proportion of the Struc-
tural Funds are allowed to be spent on RDI projects by capacity building. While some of 
these funds have been used to drive innovation forward, the effectiveness has not been 
so obvious given the criteria used for investment mitigates against high risk projects that 
do not show an obvious or quick return on investment. Likewise there are too many bod-
ies involved in the decision-making process, many with little or no experience of high-risk 13
research and there is also scant knowledge in the research community on how to manage 
large national or international projects. Currently the decisions on what investments to 
make are made by the Member State to aid capacity building. This can lead to projects that 
are not necessarily at the cutting edge. 
❫❫❫  ERAB recommends the following measures:
  ■ a greater element of risk is taken in the use of Structural Funds and a certain propor-
tion is held centrally to support projects that are speciﬁ  cally pan-European interest 
and potentially contributing to solving the grand challenges; 
  ■ urgent attention is paid to the way Structural Funds are administered such that they 
are used to maximise the return on investment not only in monetary terms directly 
but also in other areas such as training, mobility, and the raising of standards of 
research and innovation;
  ■ the training of project managers for creating and operating large research projects 
and infrastructures is a priority for long-term funding within the Structural Fund pro-
gramme. 
One of the acknowledged grand challenges is the provision of healthy food and drinkable 
water for all citizens as part of the larger challenge to move towards more sustainable 
farming.
❫❫❫  ERAB recommends that this is supported using funds from the common agriculture 
policy in order to bring further innovation into this sector.
8.  Foster an acceptable degree of risk-taking and excellence throughout 
all research, development and innovation (RDI) programmes
A new global economic and scientiﬁ  c landscape is emerging in previously poverty-stricken 
parts of the world, challenging the West in areas where Europe and the United States have 
been comfortably ahead for many years. These new economies are growing at a fast pace 
and are reassessing their traditional partners. It is essential that Europe retains and builds 
on past relationships and fosters a global approach to supporting research and develop-
ment, especially on solving global challenges. Not only should Europe’s research environ-
ment encourage these partnerships, it is also necessary that student training in Europe’s 
universities and institutions is world leading 
The challenge is not only a matter of quantity. Compared to the United States, European 
frontier research has a quality problem. This means, striving for excellence is the only 
choice Europe has in order to remain amongst the world’s most fertile areas for innovation. 
Excellent research is fostered by rigorous, transparent, fast and efﬁ  cient selection proce-
dures, which are tailored to the type and level of the proposed research: from curiosity-
driven to translational and applied research and from individual, to group and institutional 
level. 14
Widely applied traditional peer-review mechanisms tend to favour ‘safe science’ over novel 
and risky projects, especially when it comes to frontier, high-risk research. While the ERC 
has been extremely successful in encouraging high risk this has not applied to all areas of 
R & D funding research funds, which are granted on the basis of trust, are more suitable for 
research with unpredictable developments and outcomes especially where new technolo-
gies and cross-disciplinary projects are concerned. However a common understanding of 
best practice in tailored selection mechanisms still remains to be developed throughout all 
member countries of the European Union. 
The current administration of much of the framework programme does not encourage 
high risk, potentially high-impact frontier research and innovation. There is a need for 
a new model to deliver this. Any entity to do this should be independently governed at 
arms length from the Commission by a group of persons who are selected on the basis 
of their wide experience and intimate knowledge of research and innovation. It should be 
able to make long-term funding commitments to allow projects to deliver real outcomes. 
It should be accountable for its overall programme and not subject to any external control 
of its internal policy, personnel or type of project supported. It should focus on high-risk 
research and be sufﬁ  ciently ﬂ  exible to react to changing conditions and discoveries. Above 
all it should not be constrained by existing ﬁ  nancial regulations.
❫❫❫ ERAB  recommends:
  ■ establishing a set of independently governed arms-length Commission entities to 
fund and encourage frontier research and innovation based on the best practice 
found in Member States and elsewhere;
  ■ developing ‘gold standards’ and training reviewers, auditors and researchers across 
Europe.
9.  Create a European venture capital fund capable of investing in early-stage 
‘proof of concept’ and business development prior to commercial investment
Young innovative ﬁ  rms in Europe face major difﬁ  culties in accessing venture capital, as its 
availability is fragmented due to obstacles to cross-border investments and its supply is 
limited due to a less developed venture capital tradition and unattractive rates of return in 
comparison to the United States. The ﬁ  nancial crisis has further aggravated the situation, 
making it extremely difﬁ  cult for start-ups to cross the ‘valley of death’. 
❫❫❫  ERAB recommends the establishment of a major European venture capital fund with 
co-ﬁ  nancing from the European Commission, the European Investment Bank group 
and private institutional investors. 
Its characteristics should include: 
  ■ complementarity to similar national schemes within the ERA by means of pan-Euro-
pean engagement, ambition and ﬁ  eld of action;15
  ■ a multi-billion contribution from the EU budget, as required to attract sufﬁ  cient con-
tributions from co-investors for creating a substantial fund that makes a difference;
  ■ complementarity to the Risk-Sharing Finance Facility (RSFF) for investing in R & D 
and innovation;
  ■ management with a strong selection step guided by venture capital specialists, 
milestone- driven cut-off points, and an appreciation of the difference in timelines 
between different sectors (e.g. biotech vs. ICT);
  ■ focus on early-stage support to young innovative ﬁ  rms for ‘proof of concept’ and 
business development, enabling them to grow beyond their start-up phase;
  ■ access to FP beneﬁ  ciaries, with the combined beneﬁ  ts of adding value to FP research, 
driving FP research closer to innovation, attracting more SMEs to the FP, and building 
on pre-screened excellent research;
  ■ recycling of returns on investments into the fund, as this should allow the initial 
impulse from the EU budget to create a revolving fund in the longer term. 
To further increase the availability of venture capital, the following additional measures 
are required:
  ■ the establishment of an integrated venture capital market within the EU by removing 
ﬁ  scal, regulatory and bureaucratic obstacles to cross-border investments;
  ■ the creation of efﬁ  cient, integrated, pan-European trading platforms and quoted 
stock market(s) for young innovative companies;
  ■ the stimulation of business angel investments by means of dedicated networks for 
spreading best professional practices;
  ■ the provision of ﬁ  scal incentives for individual, corporate and institutional investors, 
venture capitalists, business angels and young innovative companies.
Recommendations for longer-term actions
10.  Make result and risk-oriented funding of research and innovation 
projects the dominant criterion for R&I funding of the EC
Acknowledging the time and effort needed to develop culture and processes throughout all 
Member States and the Commission, ERAB looks forward to the day when risk taking and 
a focus on tangible results will be the acceptable norm across all programmes. Thus the 
medium-term recommendation will become the way of life for the future of RDI in Europe. 
This requires a paradigm shift in the way all stakeholders view research and development 
funding. 
❫❫❫  ERAB recommends that by 2030 50 % of EC research funding should go to frontier, 
high-risk research and development.16
Europe takes the lead to address the global challenges: ‘A Davos for Research, 
Development and Innovation’
❫❫❫  To maintain momentum ERAB recommends that Europe should take the lead in invit-
ing all global stakeholders to participate on an annual basis to make top-level policies 
and monitor progress on common research and innovation (R&I) actions for tackling 
the global challenges.
This ‘Davos for Research, Development and Innovation’ will allow Europe to take a leading 
role in the world of research, development and innovation. Meetings of the World Eco-
nomic Forum demonstrate the effectiveness of this approach for world trade, ﬁ  nance and 
global policy issues. As the grand challenges before us are not conﬁ  ned to any one region 
of the world in the long term (although there is short-term priority setting for different 
areas) it is essential that there is a meeting place for all countries/regions of the world 
where decision-makers meet and are informed by the best available advice.
Since the EU created the concept and is developing the reality of the ERA, it is building up 
experience on how to bring coherence in one region of the world. Once the Member States 
have demonstrated how to successfully pool resources and develop joint programmes 
towards addressing major societal challenges, this experience should indeed be used in 
extending it to international joint programmes. This learning process could be exploited 
and further developed into an international forum in conjunction with major partners. It 
is essential that all disciplines (the point is that it is not just a question of science but 
legislators, standards, ﬁ  nance, etc), relevant ministries and decision-makers are present 
3.   Time to go global17
in order to hammer out workable solutions while allowing individual countries to select 
which projects to support as part of a ‘chess board of opportunities.’ This variable geom-
etry approach will mean that individual countries/regions can build up a critical mass of 
expertise allowing a win-win situation rather than a winner takes all if negotiations are just 
conducted on a programme-by- programme basis. 
❫❫❫  ERAB recommends that the EC starts putting together ideas on the modus operandi of 
such a forum that can then be discussed with high-level ofﬁ  cials from other regions. 
This group should be set up immediately with a timeline for the ﬁ  rst meeting of the 
forum to be held within two to three years and thereafter the forum should meet on a 
yearly basis to start new programmes and to review progress. 
While ERAB has been extensively involved in propagating its advice widely and seeking 
comments, its main role is to act as independent advisors to the European Commission. In 
the coming year it will be asked to respond to speciﬁ  c areas as will be outlined in the forth-
coming Communication on the Innovation Union Flagship Initiative. In order to reinforce 
the need to look more widely at innovation the membership and working arrangements of 
ERAB will be optimised to be as effective as possible.18
Annex 1: ERAB at work 2009–10
As part of reaching out to the stakeholders of the debate, ERAB members have actively 
advocated and communicated the ERAB’s strategic view in numerous meetings and confer-
ences around Europe.
ERAB also consulted several European institutions and advisory boards on different aspects 
of developing the future of the ERA in a meeting under the auspices of the European Sci-
ence Foundation (ESF) in November 2009. In the debate participants included ERAB, ESF, 
European Heads of Research Councils (Eurohorcs), The European Research Council (ERC), 
the League of European Research Universities (LERU), and the European Federation of 
National Academies of Sciences and Humanities (ALLEA).
Moreover ERAB briefed the Commission on a range of ongoing policy issues. 
  ■ The contribution of FP7 instruments to the establishment of a genuine European 
Research Area (February 2009).
  ■ Networks of Excellence (December 2009).
  ■ What ambition and policy design for the Research and Innovation Plan? A conceptual 
contribution from ERAB, integrating its view on the future of research and ERA with 
the innovation agenda (March 2010).
  ■ The role of venture capital for the R&I strategy (April 2010).
  ■ The role of public procurement for the R&I strategy (April 2010).
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  ■ The communication ‘Simplifying the implementation of the research framework pro-
grammes’ COM (2010) 187 (May 2010).
  ■ Achieving Cohesion in European Research and Innovation. Excellence and Cohesion: 
Two sides of the same policy coin (July 2010).
Annex 2: The ERAB 2030 milestones
Building the European Research Area is a long and difﬁ  cult task and for that we need a plan. 
ERAB’s strategic vision is described in its report, ‘Preparing Europe for a New Renaissance.’ 
To put it in concrete terms, here we list 26 goals and 76 recommended actions which we 
believe to be important steps on the road to a united and innovative ERA by 2030. They are 
divided into four broad themes, corresponding to scheduled sessions in the Seville confer-
ence. For all these milestones, we ask whether they are ambitious enough, and how they 
would be implemented.
THEME I: UNITED ERA IN A GLOBAL WORLD
ERAB vision:
goals by 2030
Recommended actions Impact by 2030
1. The  EC’s 
share of ERA-wide 
public, non-
military research 
funding doubles to 
10 %.
1.1.  The current funding for thematic 
research programmes is maintained 
to at least the present levels 
(Cooperation programme).
The innovation gap 
with the US and other 
innovation leaders is 
reduced to zero and 
Europe acts as a role 
model in research 
and innovation with 
respect to addressing 
the ‘grand challenges’, 
such as climate 
change, energy supply 
and ageing societies.
Europe increases its 
share of top-ranked 
universities (see theme 
IV) and becomes 
more attractive for 
private investment on 
research.
1.2.  The overall research budget 
is increased by adding a 10th of a 
percentage point to VAT, for the 
beneﬁ  t of research into grand 
challenges.
1.3.  30 % of the Structural Funds are 
used for research, development and 
innovation (RDI), 10 % of the common 
agricultural programme budget goes 
speciﬁ  cally to agricultural research 
dedicated to agri-based issues in 
food, health and energy.20
2. There  is 
a signiﬁ  cant 
increase in the 
coordination of 
scientiﬁ  c research 
grant programmes 
across the ERA, 
to at least 10 % of 
funding.
2.1.  A European grant union 
between Member States and the EU 
exists with a global outlook, driving 
joint initiatives.
Europe maximises the 
impact of research and 
innovation.
2.2.  Strengthen EIT in coordinating 
grant programmes in speciﬁ  c ﬁ  elds.
2.3.  Increase investment on 
European research infrastructures.
2.4.  An ERA-wide monitoring system 
tracks all joint initiatives (from 
bi-national to all), joint programming, 
intergovernmental organisation and 
cross-national shared infrastructures.
3. Mobility 
triples, with 
up to 20 % of 
EU doctoral 
candidates 
working outside 
their home 
country.
3.1.  Funding for Marie Curie-type 
programmes increases.
Young researchers 
develop a truly 
European career 
in research and 
innovation in order 
to strengthen the 
ERA and Europe’s 
competitiveness. 
At least 30 % of young 
researchers come from 
outside Europe.
3.2.  English is the standard for 
PhD and other postgraduate studies 
whenever relevant.
3.3.  Barriers to the cross-national 
movement of scientists and families 
no longer exist. Financial incentives 
are there for researchers willing to be 
mobile.
3.4.  A European research passport/
visa for successful non-European 
researchers exists which enables 
them to move easily around Europe 
and which encourages non-Europeans 
to come to ERA centres of excellence.
4. The  ﬁ  scal 
regime for R & D 
and innovation 
incentives is 
optimised across 
the EU.
4.1. Optimise  ﬁ  scal and social 
beneﬁ  ts for industries employing 
signiﬁ  cant numbers of researchers.
A dynamic and truly 
European climate for 
research investment 
exists so that more 
companies will choose 
Europe as their hub 
for RDI.
4.2.  The design and implementation 
of state aid and procurement rules are 
optimised to have the biggest impact 
on entrepreneurial activities. Create a 
strong European innovation demand 
(Aho Report).
4.3.  A pan-European uniﬁ  ed market 
for cross-national, research-related 
investments (including risk/venture 
capital) is created.21
THEME II: SCIENCE, SOCIETY AND POLICY
ERAB vision:
goals by 2030
Recommended actions Impact by 2030
5. A  third 
of public, 
non-military 
research is 
geared to 
grand societal 
challenges, 
with multi- 
and trans-
disciplinary 
approaches.
5.1.  The increase in funding as 
proposed under Milestone 1 is applied to 
this purpose.
ERA contributes lasting 
solutions to the grand 
challenges, mindful of 
their global impact.
5.2.  Europe has at least a ‘man/woman 
on the moon’ project for each grand 
challenge it wants to address and gears 
all its instruments, including PPP, to that 
end.
5.3.  Multi- and trans-disciplinary 
funding has priority for grand challenges 
research.
5.4.  Training to manage multi- and 
trans-disciplinary projects as well as to 
engage the public is a standard part of 
research education.
6. A  more 
educated 
citizenry is 
trained in 
science and 
technology 
issues to 
be able to 
participate in 
policy debate.
6.1.  All outputs of publicly funded 
research are available via ‘open access’ 
to all interested parties, and universities 
undertake a broader role in science 
communication. European citizens 
regard the results of 
decision-making based 
on scientiﬁ  c research 
as optimal for the 
common good.
6.2.  The impact of science and 
technology on the innovative power of 
society and all kind of businesses is 
underpinned.
6.3.  Open up universities to the public 
by promoting lifelong membership.
7. A  universal 
code of scientiﬁ  c 
ethics is 
adopted by the 
whole European 
research 
community, 
enunciating 
social 
responsibilities 
as well as 
intellectual 
freedoms.
7.1.  As part of the contract between 
science and society, a code of ethics is 
in place akin to the Hippocratic Oath for 
medical practitioners. Rigour (in decision-
making), Respect 
(for fellow man, 
colleagues and world), 
and Responsibility 
(for action) drive the 
relationship between 
science and society.
7.2.  All scientists sign this ethical code 
when starting their graduate studies.
7.3.  The code of ethics is part of the EU 
treaty.22
8.  30 % of 
all scientists, 
including 
those in the 
humanities and 
social sciences, 
are trained 
in research 
ﬁ  elds relevant 
to the grand 
challenges.
8.1.  European funding for Masters 
and PhD training focuses on the grand 
challenges, including attendance at 
cross-disciplinary summer schools.
The critical mass of 
students educated in 
the grand challenges 
is increased and a 
better linkage between 
investment in research 
and education is a 
reality. The grand 
challenge researcher is 
an accepted and widely 
present researcher 
proﬁ  le with full career 
opportunities.
8.2.  Internships in the business and 
public sector are part of the standard 
research curriculum.
9. The  tools 
of ‘e-science’ 
are deployed 
throughout the 
ERA, permitting 
international 
collaboration 
so that all 
researchers will 
see themselves 
as part of the 
global research 
system.
9.1.  An EU central depository for 
publications in all areas of EC-funded 
research is operational.
Open Access and 
virtual science are fully 
embedded practices in 
European research.
9.2.  Paper transactions as a means of 
communication between researchers 
and public funding organisations are 
minimised.
9.3.  EC funds prioritise online, 
postgraduate inter-university 
programmes as well as online joint 
research programmes.
10. The  EU 
and Member 
States spend up 
to three times 
as much as in 
2005 on higher 
education, or 
3.3 % of GDP.
10.1.  The increased funding (Milestone 
1) is used to better match — by 2020 
at the latest — the overall proﬁ  le of 
higher education with all skills and 
competencies needed for a knowledge-
based society. A culture of science 
and innovation thrives 
across Europe. 10.2.  Budget priorities of Member 
States with regard to research are 
reassessed to take into account the 
needs of the Knowledge Society. A 
reasonable timeline is deployed for 
monitoring, as this is a condition for 
complying with the Europe 2020 agenda.23
11. Irrespective 
of age, race or 
gender, ERA 
should exploit 
all available 
talent.
11.1.  Half of all scientists and research 
policymakers, across all disciplines and 
at all levels of the science system, are 
women.
All knowledge 
resources that Europe 
has are maximised for 
the common good.
11.2.  Restrictions on the age of 
competent researchers should be lifted 
where they exist.
11.3. Speciﬁ  c grants are in place for 
parents taking up research after family 
leave.
11.4.  Childcare provisions are 
compulsory for all higher-education and 
research institutes.
11.5.  Enabling parents on family 
leave to take full advantage of the 
opportunities of e-science is compulsory 
and at zero cost for the beneﬁ  ciary.
12. The  EU 
has a fully 
functioning, 
independent 
Chief Scientiﬁ  c 
Advisor, 
supporting 
its decision-
making with the 
best available 
evidence, 
horizon-
scanning and 
future scenario 
planning.
12.1.  A clear functional speciﬁ  cation 
and strong proﬁ  le for the CSA (who has 
to report directly to the President of the 
EC) is deﬁ  ned immediately.
Policy decisions 
are evidence-based 
to bridge the gap 
between society and 
decision-making, and 
increases the public 
conﬁ  dence in European 
political decisions 
related to science and 
innovation.
12.2.  Foresight and participatory 
technology assessment are standard in 
policy design and decision-making.24
THEME III: OPEN INNOVATION
ERAB vision:
goals by 2030
Recommended actions Impact by 2030
13. A  pan-
European Open 
Innovation 
Charter is 
signed by 
all major 
stakeholders.
13.1.  The Open Innovation Charter is in 
place and is a reference in the selection 
criteria and guides for applicants in 
framework programme 8. Key enablers 
for open innovation are the guidelines of 
the Responsible Partnering Handbook.
Open Innovation is the 
default position for 
European research and 
the Open Knowledge 
Institution is an ISO 
standard for higher 
education and 
research.
13.2.  State aid rules and their 
interpretation are reviewed and 
redrafted to enable maximum ﬂ  exibility 
in the support of research and 
innovation.
13.3.  We achieve full implementation 
of the existing recommendations on 
intellectual property and partnership — 
e.g. the 2008 EC Recommendation on the 
management of intellectual property in 
knowledge transfer activities and Code 
of Practice for universities and other 
public research organisations.
13.4.  A pan-European label, ‘Open 
Knowledge Institution’, for higher 
education and research, acts as a gold 
standard for excellence in innovation in 
the ERA.
13.5.  A single, strong and credible 
European patent is established by 2015.25
14. Overall 
R & D funding 
rises to 5 % of 
GDP, of which 
industrial R & D 
accounts for 
two thirds.
14.1.  Implement the wide range 
of policy measures necessary at 
European and national levels to improve 
framework conditions — and hence 
expected returns — 
for private investments (including 
venture capital) in R & D and innovation. 
Promote Private Public Partnership 
(PPP) to stimulate investments in the 
development of new technologies.
The grand challenges 
create a strong market 
demand for innovative 
products and services 
to ‘pull through’ 
innovation and trigger 
more public and 
private investments 
in the Knowledge 
Triangle.
14.2.  A reasonable timeline is deployed 
(and monitored) to make sure there is 
a doubling of government expenditure 
on R & D to reach 1.7 % of GDP by 2030, 
and a tripling of business expenditure on 
R & D to reach 3.3 % of GDP by 2030. In 
these calculations the contributions of 
EU funding are included.26
15. 2  % 
of public 
procurement 
ERA-wide is 
earmarked for 
innovative and 
pre-commercial 
technologies, 
and is open to 
European-wide 
competition.
15.1.  Expand the EU Lead Market 
Initiative (also addressing societal 
challenges) and stimulate Member 
States to participate more actively, while 
developing similar initiatives at national 
level. Develop metrics to monitor public 
procurement of innovative technologies 
that are commercially viable and do not 
require further R & D, and systematically 
gather data on public procurement of 
R & D.  
New technologies are 
available and used for 
dealing with the grand 
challenges.
15.2.  Explicitly make public 
procurement a policy vehicle to promote 
R & D and innovation, comparable to the 
Green Public Procurement approach. 
Encourage governments to bundle public 
procurement among Member States in 
order to create more interesting markets. 
Specify functional performance rather 
than technical details in procurement 
tenders.  
15.3. 2020:  Pre-Commercial 
Procurement (PCP) of R & D is 
mainstreamed at national, regional and 
local levels and public procurers have 
tools for managing rather than avoiding 
risks.
15.4. Complement  Pre-Commercial 
Procurement at national, regional and 
local levels with the introduction of an 
SBIR scheme at European level, fully 
open to participation by procurers and 
suppliers across the EU.  
15.5.  Make (part of) EU co-funding 
in the context of the Structural Funds 
conditional on procurement of innovative 
technologies and R & D. This is also 
a means of gearing cohesion policy 
more towards stimulating R & D and 
innovation.27
16. Mobility 
of researchers 
between the 
public and 
private sector is 
high.
16.1.  A doubling in industrial funding 
of academic research from 6.7 % in 2006 
is achieved by changing the structural 
interactions between private and public 
funding.
Public–private 
research portfolios and 
careers are common.
16.2.  Marie Curie schemes are 
expanded to support professional or 
industrial doctorates.
16.3.  Industrial achievements are fully 
taken into account for academic career 
paths. A code of best practice is there to 
monitor this.
16.4.  Legal and ﬁ  scal barriers no longer 
disadvantage the movement between 
public and private sectors.
17. Risk 
capital 
available for 
early-stage 
technology 
rises up to 
0.15 % of GDP.
17.1.  Large pan-European venture 
capital funds, co-ﬁ  nanced by the 
private ﬁ  nancial sector, are active, and 
funding of the EIF is expanded to match 
other continents (taking into account 
increased support from the European 
Commission, EIB and other public 
funding sources).   More start-ups can 
grow out of the ‘valley 
of death’. 17.2.  Fiscal, regulatory and 
bureaucratic obstacles to cross-border 
risk capital investments are removed.
17.3.  In addition to the EIB a pan-
European seed capital fund supports 
proof of concept and early-stage 
development.28
THEME IV: AN ERA TO DELIVER EXCELLENCE AND COHESION
ERAB vision:
goals by 2030
Recommended actions Impact by 2030
18.  50 % of 
EC research 
funding is going 
to frontier, 
high-risk 
research and 
development.
18.1.  Develop a pan-European training 
programme that helps reviewers, 
auditors and researchers to identify and 
select promising high-impact research 
even if there is an associated risk.
The more complex 
needs of excellent 
frontier research, 
providing maximum 
beneﬁ  t, are 
understood.
18.2.  A protocol stipulating a level of 
tolerable risk in research is agreed upon 
and applied to research performance-
related auditing processes.
19. Europe 
increases 
its share of 
top-ranked 
universities to 
up to 40 % of 
the top 20 & 
100 rankings, 
and increases 
its most-cited 
research 
worldwide by a 
third.
19.1.  The European higher education 
system is functionally diversiﬁ  ed 
(teaching, research, technical skills). 
Fact-based metrics ﬂ  ag those groups 
that have high impact in R & D 
speciﬁ  cally in grand challenges. The EC 
supports this accordingly.
Europe’s higher 
education system is 
globally competitive.
19.2.  Member States revisit the 
statutes/governance of their universities 
with a perspective to contribute to a 
competitive and excellent ERA.
19.3.  To achieve a European-wide 
increase of standards, collaboration 
between higher- and lower-ranked 
universities is supported in all areas.
20. The 
governance 
system for 
European 
research 
funding will be 
based on a set 
of arms-length 
agencies, as 
part of an ‘ERA 
of Agencies’.
20.1.  A functional system of 
coordinated agencies to support ERA 
is created, with the establishment 
of agencies for fundamental 
research, applied research, research 
infrastructures, training and mobility, 
policy and strategy and exploitation/
valorisation of research.
The ERA is operational 
on a distributed 
agency model, 
governed on the basis 
of excellence and 
ﬂ  exibility.
20.2.  Coordination is strengthened 
while governance is attributed on the 
basis of competence and not necessarily 
source of ﬁ  nancing.29
21. Funding 
for public, 
non-military 
research is 
increasingly 
concentrated 
in research-
intensive 
institutions.
21.1.  A restricted number of European 
research institutes with enough critical 
mass for research and an ambition of 
global excellence is agreed on.
At least 50 of our 
innovation clusters, 
out of about 2 000 
clusters large and 
small today, are world 
leaders in scale and 
quality.
21.2.  The potential of locating 
infrastructures in countries that have a 
deﬁ  cit of representation in top-ranked 
institutions should be explored also 
through the use of Structural Funds.
22. The 
share of the EU 
budget devoted 
to research 
triples to 12 %.
22.1.  More Structural Funds 
progressively go to support leading-edge 
research.
Current deﬁ  cits, 
in comparison to 
countries that are 
leaders in enterprise, 
are corrected. All 
European talent, 
irrespective of its 
geographical location, 
contributes to a 
successful European 
economy.
22.2.  A 10-year funding scheme 
(diminishing over that time period) is 
in place by 2015 to support speciﬁ  c 
collaboration between research centres 
and universities in emerging economies 
with top EU centres elsewhere.
22.3.  Grant and project competitions 
targeted to Member States with GERD 
below the EU average are put in place 
to stimulate quality groups through 
competition and thus bridge the gap 
with Europe’s leading research locations. 
Selection, however, will be on the basis 
of excellence criteria only as in the 
current ERC competitions.
23. At  least 
30 % of the 
Structural 
Funds are used 
exclusively for 
RTD (fostering 
partnerships, 
supporting 
pre-commercial 
procurement 
and investing 
in large-scale 
research 
infrastructures 
where needed) 
— double 
the current 
allocation.
23.1.  Actions aimed at delivering this 
goal should be initiated without delay 
with particular emphasis on investing in 
infrastructures that are accepted by the 
ESFRI system.
Excellent research 
facilities and research 
activities are equally 
distributed and 
accessible across 
Europe.
23.2. Cost-beneﬁ  t analysis on any 
expenditure for RTDI should fully take 
into account the signiﬁ  cant contribution 
of intangible assets of research that 
contribute signiﬁ  cantly to tangible 
outcomes such as jobs, etc.30
24. More 
than 75 % of 
the overall 
EU budget 
is oriented 
towards 
investing in 
its future as 
a knowledge-
based society.
24.1.  Funds for successful partnering 
models that foster good governance and 
innovation are available.
The EU budget effort 
fully reﬂ  ects the needs 
of a knowledge-based 
society and economy.
24.2.  A roadmap outlining a holistic 
approach to get to this target is 
needed by 2012. European Society and 
Enterprise will need RTDI in all sectors 
and RTDI therefore cannot be considered 
in a siloed manner associated with a 
single directorate-general. Hence each 
Commissioner will have to integrate 
RTDI into their plans, and the budget 
associated with it included in the 
calculation of overall RTDI expenditure.
25. The 
major research 
institutions 
of the well-
developed 
regions of 
Europe work in 
partnerships, 
based on 
excellence, 
with those of 
the lesser-
developed 
regions.
25.1.  Special funds are available to 
support successful partnering models 
that foster good governance and 
innovation.
The impact of ERA 
is delivered by the 
actions of all regions of 
Europe.
25.2.  Incentives to promote durable 
inter-university collaborations in 
complementary converging ﬁ  elds are 
particularly welcomed.
26. Half 
of the adult 
population 
has achieved 
tertiary 
education — 
double today’s 
rate.
26.1.  This is essential to achieve an 
innovative EU 2020.
A signiﬁ  cantly higher 
number of Europeans 
will contribute to an 
innovation-based 
economy and society.31
Annex 3: ERAB Conference, ‘Preparing Europe 
for a New Renaissance’, 6–7 May 2010
Overall objective was:  
The conference brought together the most important public and private stakeholders of the 
European Research Area (ERA) to discuss the implementation of the Strategic View on ERA, 
published in September 2009 by the European Research Area Board (ERAB). The confer-
ence mainly addressed the question: ‘Can we make a true ERA really work in the future?’ 
The necessary policies and measures for the implementation of the ERAB view were exam-
ined and discussed. Special attention was devoted to the opinions of young researchers of 
today, who will be the leaders of research and the decision-makers on research policy in 
2030 and beyond. 
Audience:
The stakeholders included public and private research organisations, companies, poli-
cymakers at the national and European level and academia. Selected representatives of 
the key stakeholders were expected to play an active role in the conference by providing 
materials for a participants’ exhibition and by participating in round-table discussions with 
young researchers. The total number of participants was limited to 250 and they were per-
sonally invited. The conference had 240 participants, 50 of them were young researchers.
Programme: 
Welcome and opening remarks
  ■ Prof. John Wood, European Research Area (ERAB) and Conference Chair
  ■ Ms Montserrat Torné i Escasany, Director-General for International Cooperation 
and Institutional Relations, Ministry for Science and Innovation 
  ■ Ms Máire Geoghegan-Quinn, European Commissioner for Research, Innovation 
and Science
  ■ Dr Ronald Schenkel, Director-General of the Joint Research Centre (JRC)
Plenary sessions
Session 1 — The ERAB Strategy 2030: the long-term view
Chair:  
  ■ Prof. John Wood, European Research Area Board (ERAB), United Kingdom
Rapporteur: 
  ■ Mr. René van Bavel, JRC–IPTS, Spain32
Objectives:
Present the ERAB Strategic View and put it into an international perspective.
  ■ Prof. John Wood, European Research Area (ERAB), United Kingdom 
  ■ Prof. Han Jianguo, Director-General, Bureau of International Cooperation, 
National Natural Science Foundation of China, China
  ■ Mr Daan du Toit, South Africa’s Senior S&T Representative to the EU
  ■ Prof. Nicholas S. Vonortas, Director, Centre for International Science and Tech-
nology Policy, The George Washington University, US (as presented by Richard 
Hudson, CEO and editor, Science|Business, The media network for research, 
industry and policy, Belgium) 
Session 2 — Is the ERAB Strategy 2030 ambitious enough?
Chairs: 
  ■ Prof. Marja Makarow, CE, European Science Foundation (ESF), France
  ■ Prof. Carlos María Romeo-Casabona, Inter-University Chair in Law and the Human 
Genome, University of Deusto, Spain
Rapporteur: 
  ■ Dr Vanessa Campo-Ruiz, European Science Foundation (ESF), France
Objectives:
In view of mankind’s grand challenges for the immediate and long-term future, and tak-
ing into account the emerging economies around the world, Europe needs to design 
a research strategy that is ambitious and risk-tolerant, strives for true excellence and 
competitiveness but also maintains our core societal values. Research organisations, 
industries, policymakers and the civil society must all ﬁ  nd a common ground for action 
in the spirit of open dialogue. The ERAB Strategy 2030 identiﬁ  es six main areas where 
a united European Research Area is a necessity, and describes an optimal scenario for 
a successful ERA. This session’s objective is to examine whether the view is ambitious 
enough.
  ■ Dr Molly Stevens, Imperial College of Science, Technology and Medicine, ERC 
Starting Grant Award 2007, United Kingdom  
  ■ Mr Francisco Belil, Chief Executive Ofﬁ  cer Siemens, S.A., Spain & Cluster South 
West Europe, Spain
  ■ Prof. Eva Malmström-Jonsson, Deputy President, Kungl Tekniska Högskolan, 
Sweden
  ■ Mr Lars Kolind, Chairman of the Board of Poul Due Jensen Foundation (Grundfos), 
Denmark33
Parallel sessions
Each session is introduced and moderated by an ERAB member, and animated by inter-
ventions from stakeholders and a young researcher.
Session 3: United ERA in a global world
Chairs:
  ■ Prof. Georg Winckler, Rector, University of Vienna, Austria
  ■ Prof. Zaneta Ozolina, Faculty of Social Sciences, University of Latvia
Rapporteur:
  ■ Dr John H. Smith, Deputy General Secretary, European University Association 
(EUA), Belgium
Objectives:
Europe faces mounting economic difﬁ  culties, and a consequent fascination with leaders 
and policies that put the immediate, local interest ﬁ  rst and the longer-term common 
interest second. ERAB warns against emerging research nationalism and advocates that 
unless we complete a common market in research and innovation, unless we make the 
European Research Area a fully functioning reality, our progress will stagnate. A united 
ERA is a place where there will be no barriers to either researchers or ideas moving 
freely from country to country, private to public sector (and vice versa), or between 
disciplines. 
  ■ Dr Sylvia Schwaag-Serger, Director International Collaboration and Networks, 
Swedish Agency for Innovation Systems (VINNOVA), Sweden
  ■ Prof. Bernard Bigot, Chairman, French Atomic Energy Commission (CEA), France
  ■ Prof. Dieter Imboden, President Eurohorcs, Switzerland
Session 4: Science, Society and Policy 
Chairs: 
  ■ Dr Leif Kjaergaard, President, LEIF and FOOD Science, Denmark
  ■ Prof. Nüket Yetis, President, Scientiﬁ  c and Technological Research Council of Tur-
key (TÜBITAK), Turkey
Rapporteur: 
  ■ Dr Susana Elena-Pérez, JRC–IPTS, Spain
Objectives:
The speed of innovation will increase and this acceleration of change will pose addi-
tional challenges for our societies. We therefore must increase our awareness of the 
extent by which scientiﬁ  c and technical innovations affect social and economic pro-
cesses. It is also important that our complex societies need scientiﬁ  c research to sup-
port long-term evidence-based decision-making in society. In order to gain a greater34
trust between science and society, we need a new ‘social contract’ between them that 
emphasises not just the researcher’s freedom of thought but also the responsibility of 
scientiﬁ  c action. We have learned that every powerful new technology can have bad as 
well as good consequences, and researchers can no longer ignore the ensuing political 
debate over how their discoveries will be used. Scientiﬁ  c excellence, therefore, must be 
paired with social awareness and responsibility.
  ■ Prof. Michal Kleiber, President of the Polish Academy of Sciences and Advisor to 
the President of the Republic of Poland, Poland
  ■ Dr Barbara Haering, Econcept INC, Switzerland 
  ■ Prof. Maria Anvret, Senior Advisor to the CEO, Confederation of Swedish Enter-
prise, Sweden
  ■ Dr Gonçalo Lobo Xavier, Executive Director, Portuguese Technological Centers 
Network (RECET), Portugal
Opening of second day proceedings
Keynote speech: Dr. Martin Schuurmans, Chair of the European Institute of Innovation 
and Technology (EIT), Hungary
Parallel sessions
Each session is introduced and moderated by an ERAB member, and animated by inter-
ventions from stakeholders and a young researcher.
Session 5: An ERA of Open Innovation — Public and Private Partnership 
Chairs:
  ■ Prof. Lena Treschow Torell, Chairman, Royal Swedish Academy of Engineering 
Sciences, Sweden
  ■ Mr Reinhold Achatz, Siemens AG Corporate Technology, Corporate Research and 
Technologies, Germany
Rapporteur: 
  ■ Prof. Maria Cristina Pedicchio, President Cluster in Biomedicine, Italy
Objectives: 
‘Open innovation’ by 2030 means that the entire European system for getting ideas 
from lab to market in Europe, from input to output, must be open to all players. At 
present, an array of barriers impedes this free exchange of capital and ideas. Conﬂ  icting 
ﬁ  scal policies, from Member State to Member State, fragment the risk capital markets 
and make it harder to fund high-risk technology start-ups; they also skew investment 
decisions by large companies. The lack of a coherent intellectual property system raises 
costs and magniﬁ  es risk. Furthermore, the lack of incentives and non-supportive taxa-
tion systems in the EU hampers private investments in research and innovation from35
the private sector and from private donations. Our innovation clusters are undersized. 
Funding — needed to build the research facilities, schools and social amenities that 
make a cluster attractive — is scattered and uncoordinated. In short, we need a genuine 
‘single market’ for innovation in Europe promoted by regulatory incentives and a sup-
porting taxation system.
  ■ Prof. Geneviève Berger, Chief Research & Development Ofﬁ  cer, Unilever House, 
United Kingdom 
  ■ Mr Ulf Wahlberg, Vice President, Industry and Research Relations, Ericsson AB, 
Sweden
  ■ Prof. Jan-Erik Sundgren, Senior Vice-President, Volvo AB, Sweden
Session 6: An ERA to deliver excellence and cohesion
Chairs:
  ■ Dr Ingrid Wünning Tschol, Head of Science and Research Department, Robert 
Bosch Stiftung GmbH, Germany
  ■ Prof. Frank Gannon, Director-General, Science Foundation Ireland, Ireland
Rapporteur: 
  ■ Prof. Frank Gannon, Director-General, Science Foundation Ireland, Ireland
Objectives: 
Excellence and Cohesion are potentially opposing goals. But both must be addressed in the 
European Research Area. In this session the steps towards selecting excellent projects will 
be addressed with the realisation that mere quality is not sufﬁ  cient if research is also going 
to be an economic driver. How should peer reviewing — characterised as it is as being risk-
averse — address the challenge of selecting the best projects and, simultaneously, ensure 
that sufﬁ  cient outcomes from the labs will translate directly or indirectly to the economic 
sector? Will the selection of the top applications on quality only result in the exclusion to 
large areas of European Community and what steps should be taken to achieve coherence 
and cohesion in such a system? Will the processes to increase the quality and the impact 
of research in the ERA eventually become common to all Member States? Excellence can 
also mean excellent strategies on how to improve science and research in a given region. 
Ultimately the ERA will have to achieve an increase in quality in a manner that strengthens 
all countries and this means developing a wide range of funding instruments — cohesion 
programmes, infrastructure development, mobility grants and developing tools to make 
the most prudent choices to match speciﬁ  c needs in the system.
  ■ Dr Jana Kolar, Director-General of the Directorate of Science at the Ministry of 
Higher Education, Science and Technology, Slovenia
  ■ Prof. Daniel Zajfman, President of Weizmann Institute of Science, Israel 
  ■ Prof. Maria Leptin, Director, European Molecular Biology Organisation (EMBO)
  ■ Prof. Patrick Cunningham, Chief Scientiﬁ  c Advisor, Ireland36
Plenary session 
Session 7 — Optimising the ERA by 2030
Chair: 
  ■ Ms Anneli Pauli, Deputy Director-General, DG Research, European Commission
Rapporteur: 
  ■ Mr Ken Guy, IPTS–JRC, Spain
Session rapporteurs’ reports and discussion on actions to implement the strategy.
The output will be a set of recommendations targeted to all major stakeholders.
Concluding remarks
Chair: 
  ■ Dr Leif Kjaergaard, President, LEIF and FOOD Science, Denmark
Speakers:
  ■ Ms Anneli Pauli, Deputy Director-General, DG Research, European Commission 
  ■ Ms Angeles Rodriguez Peña, Deputy General Director of European Programmes, 
Ministry of Science and Innovation
  ■ Ms Ines Sanchez de Madariaga, Director — Unit of Women and Science, Ministry 
of Science and Innovation
  ■ Ms Caroline Mancel, Attaché, the Permanent Representation of Belgium to the EU37
About the European 
Research Area Board
The 22 members of ERAB were announced in April 2008, to advise the European Commis-
sion on research and science policy with a view to creating the European Research Area. 
Its members are:
Dr. Reinhold ACHATZ, Corporate Vicepresident, Siemens AG, Corporate Technology, 
  Corporate Research and Technologies (DE)
Dr. Robert AYMAR, Former Director General of the European Organization for Nuclear 
Research (CERN)(CH); Scientiﬁ  c Counsellor to the Administrator of CEA (FR)
Dr. Lajos BALINT, Director of International Relations, National Information Infrastructure 
Development Institute (HU)
Dr. Jean J BOTTI, Chief Technical Ofﬁ  cer, EADS (DE)
Dr. Adelheid EHMKE, Former President, European Platform of Women Scientists EPWS (BE)
Prof. Frank GANNON, Director General, Science Foundation Ireland (IRL)
Dr. Barbara HAERING, Chief Executive Ofﬁ  cer, ECONCEPT Inc. (CH)
Prof. Sir David KING, Founding Director, Smith School of Enterprise and the Environment 
– University of Oxford (UK)
Dr. Leif KJAERGAARD, President of LEIF and FOOD SCIENCE, former Chief Technology 
Ofﬁ  cer of Danisco A/S, (DK)
Prof. Marja MAKAROW, University of Helsinki (FI), and Chief Executive, European Science 
Foundation (FR)
Prof. Karol MUSIOL, Rector, Jagiellonian University, Krakow (PL)
Prof. Zaneta OZOLINA, Faculty of Social Sciences, University of Latvia (LV)38
Prof. Maria Cristina PEDICCHIO, Faculty of Sciences, Università di Trieste and President, 
Cluster in Biomedicine (CBM) (IT)
Prof. Alain POMPIDOU, Centre National de la Recherche Scientiﬁ  que (CNRS) (FR)
Prof. Carlos Maria ROMEO-CASABONA, Director, Inter-University Chair in Law and the 
Human Genome, University of Deusto and University of the Basque Country (ES)
Dr. Unni STEINSMO, President, Chief Executive Ofﬁ  cer, SINTEF (NO)
Prof. Lena Treschow TORELL, President, Royal Swedish Academy of Engineering Sciences (SE)
Dr. Jan VAN DEN BIESEN, Vice-president Public R&D Programs, Philips Research (NL)
Prof. Georg WINCKLER, Rector, University of Vienna, former President, European Univer-
sity Association (AT)
Prof. John WOOD, Secretary General, The Association of Commonwealth Universities (UK)
Dr. Ingrid WÜNNING TSCHOL, Head of Science and Research, Robert Bosch Stiftung (DE)
Prof. Nüket YETIS, President, The Scientiﬁ  c and Technological Research Council of Turkey 
(TR)
The European Research Area Board is chaired by Prof. John Wood. The Vice Chairs are 
Dr. Leif Kjaergaard and Dr. Ingrid Wünning Tschol. Together with Prof. Marja Makarow, 
Prof. Lena Treschow Torell and Dr. Georg Winckler, they form the ERAB Bureau.
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The European Research Area Board (ERAB) was established in 2008 
to provide independent and authoritative advice to the European Commission
on research and science policy with a view to creating the European Research Area. 
Its 22 eminent members are drawn from the ﬁ  elds of science, academia and business.
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